Cell coding company bit.bio has announced an expansion to its product portfolio - ioGlutamatergic Neurons TDP-43M337V disease model and early access to its ioMicroglia...
Astellas Venture Management LLC, a wholly-owned venture capital subsidiary of Astellas Pharma Inc., and Mission Bay Capital BioLabs ("MBC BioLabs"), a life-science incubator, today...
Artisan Bio, a world-leader in CRISPR genome engineering technology, announced the launch of its CRISPR-based 1-stop shop developed from the company's proprietary STAR-CRISPR platform....
Frost & Sullivan's recent analysis, Global Pharmaceuticals Outlook, finds that the accelerated drug development timelines are driving digitalization and innovation across the pharmaceutical value...
Axol Bioscience Ltd. (Axol), an established provider of iPSC-derived cells, media, and characterization services for life science discovery, announced that its human induced pluripotent...
